Natural Beauty Bio-Technology Limited

Symbol: 0157.HK

HKSE

0.51

HKD

Market price today

-67.5714
P/E Ratio
-2.4025
PEG Ratio
1.02B
MRK Cap
0.00%
DIV Yield

Natural Beauty Bio-Technology Limited (0157-HK) Financial Statements

Download

Annual Quarterly

Linear Log

On the chart you can see the default numbers in dynamics for Natural Beauty Bio-Technology Limited (0157.HK). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Annual Quarterly

10Y 20Y 30Y 40Y

Balance Sheet

Diving into the fiscal trajectory of Natural Beauty Bio-Technology Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	166.8	168.6	197.1	165.6	149.1	183.9	288.9	428.6	502.7	583.3	507.4	432.4	558.7	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	304.9	141.9
balance-sheet.row.short-term-investments	8.1	8	8.9	7.5	10.1	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.1	65.8
balance-sheet.row.net-receivables	85.4	80.9	119.9	118.9	103.7	71.3	98.2	73	41.2	50.8	83.7	55.1	0	44.7	0	93	0	164.9	141.2	124.6	130.7	0	0
balance-sheet.row.inventory	77.6	98.8	121	103.3	85.5	74.3	85.1	49.8	46.9	45	47	67.4	40.3	46.7	89.1	100.9	71	63.6	56.5	55.7	62.7	52.7	52.7
balance-sheet.row.other-current-assets	13.3	16.3	12.1	12	21.2	18.2	19.7	14.5	18.8	17	29.3	0.3	56.2	0.4	86.1	0.4	99.2	28	26.7	94.4	67.6	101.1	64.4
balance-sheet.row.total-current-assets	343	364.6	450	399.8	359.5	347.8	491.9	565.9	609.6	696.1	667.4	555.2	655.2	667.3	734.5	740.5	759	612.7	563.2	510.6	431.3	458.8	258.9
balance-sheet.row.property-plant-equipment-net	270.6	238.4	417.1	369.6	345	197.2	198.6	173.5	187.4	223.7	257.2	285.1	261.1	232.1	217.8	230.6	218	335.7	338.4	353.4	352.5	362.2	377.7
balance-sheet.row.goodwill	25.2	25.7	29.6	28.8	27.4	31.4	27.1	25.5	27	28.3	28.4	27.6	27.5	26.6	25.8	25.8	24.6	23.2	13.9	16.8	23.6	0	0
balance-sheet.row.intangible-assets	0	25.7	35.3	42.9	42.4	17.1	27.1	25.5	27	9.1	9.5	9.5	0	0	0	0	0	0	0.9	2.1	3.2	16.5	5.5
balance-sheet.row.goodwill-and-intangible-assets	25.2	51.4	64.9	71.7	69.8	48.5	27.1	25.5	27	28.3	28.4	37.1	27.5	26.6	25.8	25.8	24.6	23.2	14.8	18.9	26.8	16.5	5.5
balance-sheet.row.long-term-investments	217.7	228.7	9.5	8.8	7.9	11.2	7.9	8.9	10.2	250	284.6	-6.3	0	0	0	0	0	7.2	7.3	7.4	12.2	-76.9	-61.3
balance-sheet.row.tax-assets	24.4	25.2	25	19	12.9	5.2	217.8	190.2	0.6	2	1	0.7	0	0	3	9.2	7.5	9.4	4.7	4.7	9.8	0.8	1
balance-sheet.row.other-non-current-assets	1.6	-24.7	-29.3	-28.1	-27	-16.4	-225.7	-199.1	-10.8	-252	-285.6	12.3	14.8	14.9	18.2	20.2	23.2	9.5	9	5.2	8.7	100.1	65.8
balance-sheet.row.total-non-current-assets	539.5	518.9	487.1	441	408.6	245.7	225.7	199.1	214.4	252	285.6	328.8	303.4	273.6	264.8	285.7	273.3	385	374.3	389.6	410.1	402.7	388.6
balance-sheet.row.other-assets	0	0	0	0	0	85.4	60.3	57.2	64.6	29.7	29.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.account-payables	20.7	9.8	15.2	26.1	26.2	20.5	21.5	20.9	14.9	18.6	21.3	18	135.8	126.1	93.8	106	90.3	70.2	82	55.5	53.7	82.8	135.2
balance-sheet.row.short-term-debt	171.7	119.4	94.8	59.5	22.1	-22.6	-6	-6.2	-6.6	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.tax-payables	3	7.5	19.3	9.7	4.7	9.7	18.4	24.3	28	43.8	26.7	12.7	12.8	9	14.5	41.2	4.7	27.6	15.8	20.7	13.5	11.3	20.8
balance-sheet.row.long-term-debt-total	3.5	6	9.5	2.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	24.1	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	71.2	104.8	114.4	107.2	82.5	105.3	94.1	141.8	128.7	172.6	159.6	108	19.3	19.6	24.8	51.6	14.5	37	24.2	29.9	18.8	16.6	20.8
balance-sheet.row.total-non-current-liabilities	24.7	35.3	41.3	24.9	42.1	1.3	11.5	4.8	12.3	12.6	13	10.1	15.3	12.6	11.9	12.3	11.9	11.3	10.9	10.2	8.4	7.6	6.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	11.1	18	24.8	13.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	308.1	286.1	279.2	229.5	200.3	127.1	127.1	167.5	156	203.8	193.8	136.1	170.4	158.3	130.5	169.8	116.7	118.5	117.2	95.6	80.8	107	164.9
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.2	200.1	200	0	0	0	0	0	0
balance-sheet.row.retained-earnings	39.1	54.6	85.4	50.3	42.8	189.1	259	314	355.5	361.3	365	169.8	0	0	0	0	0	0	0	0	0	118.2	105.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	263.6	271.1	294.7	277.1	241.3	255.1	284.9	220.4	256.8	128.8	139.5	-129	-104.1	-96.2	-117.3	-118.7	-141.8	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	71.6	71.6	77.6	83.6	83.6	-92.6	-93.3	-79.9	-79.9	83.6	83.6	507.1	691.9	678.4	785.2	768.6	851.4	878.7	813.5	795	750.4	615.9	348.7
balance-sheet.row.total-stockholders-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748.2	788	782.5	868.1	850	909.6	878.7	813.5	795	750.4	734.1	454.3
balance-sheet.row.total-liabilities-and-stockholders-equity	882.6	883.5	937.2	840.8	768.1	679	777.9	822.2	888.6	977.7	982.1	884.1	958.6	940.9	999.3	1026.2	1032.3	997.7	937.5	900.2	841.4	861.5	647.5
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	-0.2	0.2	0.1	0.7	6.4	6	0.4	6.8	9.7	10.2	20.3	28.3
balance-sheet.row.total-equity	574.5	597.5	657.9	611.2	567.8	551.9	650.7	654.7	732.6	773.9	788.3	748	788.2	782.6	868.8	856.4	915.7	879.2	820.3	804.6	760.6	754.5	482.6
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	225.8	236.7	18.4	16.3	18.1	2.9	7.9	8.9	10.2	250	284.6	-6.3	0	0	3.9	5.9	9.1	7.2	7.3	7.4	12.2	11.3	4.4
balance-sheet.row.total-debt	186.3	143.5	129.1	75	52.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1
balance-sheet.row.net-debt	27.5	-17.1	-59.1	-83.1	-86.1	-181	-288.9	-428.6	-502.7	-583.3	-507.4	-432.4	-558.7	-575.5	-559.3	-546.2	-588.7	-356.2	-338.7	-235.9	-170.3	-216.8	-74

Cash Flow Statement

The financial landscape of Natural Beauty Bio-Technology Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	155.3	173.6	75.8	186.8	308.5	208	122.8	81	62.7	54.1	66.5	71
cash-flows.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	0	0	0
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	-12.2	-29.6	43.1	-38.6	-44.4	0	-61.1	-35.3	-50.8	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	9.3	1.1	1	-28	30.2	0	0.5	0.2	0.1	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	4.4	-0.1	-35.8	-28.1	-45	19.7	-65.7	-33.1	2.8	28.5	-44.1	-55.6	-3.5	86.4	-6.5	-14.9	110.1	-42.6	-45.9	18.5	-62.3	0	0
cash-flows.row.account-receivables	1	19.7	6.7	0.3	-42.7	25	-28.4	-29.9	9.1	31.7	-58	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	16.5	-1	-27	-24.7	-17.7	-5.3	-37.3	-3.3	-6.3	-3.3	13.9	-35.9	3.7	14.9	-3.2	-27	-7.4	-8.4	-9.2	7	-22.2	0	0
cash-flows.row.account-payables	-16.1	-23.3	-16.6	12.7	10.4	-11.7	-40.9	14.7	-35.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	3	4.4	1	-16.5	5	11.7	40.9	-14.7	35.8	0	0	-19.7	-7.2	71.5	-3.4	12.1	117.6	-34.1	-36.6	11.5	-40.1	0	0
cash-flows.row.other-non-cash-items	0.3	4.6	8.4	13.2	12.5	3.6	-39.1	-9.8	-42.7	25.5	53.9	-7	-8.7	-7.9	12.9	-6.3	-10.7	4.1	50.9	43.8	18.2	-17.8	40.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.acquisitions-net	0	0.3	8.2	20.1	0	-18.9	0	0	0	0	0	0	0	0	0	-3.5	1	0	0	0	-7.2	-0.9	-0.8
cash-flows.row.purchases-of-investments	0	0	-1.3	-25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	-9	3.2	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	9	25	0	9.6	0.3	30.8	-31.7	13.8	9.4	10.6	10.2	9.5	12.9	36.5	165.2	-10.5	74.7	-8.9	14.9	-19.6	-11.9
cash-flows.row.net-cash-used-for-investing-activites	-69.1	-44	-31.2	-50.6	-63.7	-61.1	-32	11.7	-46.1	-4.7	-13.1	-50.6	-40.5	-27.7	-4.2	-2.4	112.4	-21.8	49.8	-23.1	-4	-66.2	-87.1
cash-flows.row.debt-repayment	-54.3	-31.2	-27.2	-38.8	-24.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2.1	-0.2
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-6	-6	0	0	-96.1	-99.7	-140.5	-142.3	-74.7	-25.6	-140.2	-160.2	-150.2	-137.1	-300	-185	-80.3	-61.3	-45	-52.3	-94.2	-39.8
cash-flows.row.other-financing-activites	104	55.3	47.6	68.6	45.1	0	-60.9	-50.1	0	0	0	-0.8	0	0	0	0.4	5.1	0	0	0	0	254	9.5
cash-flows.row.net-cash-used-provided-by-financing-activities	49.6	18.1	14.3	29.9	20.2	-96.1	-160.6	-190.6	-142.3	-74.7	-25.6	-140.9	-160.2	-150.2	-137.1	-299.7	-179.9	-80.3	-61.3	-45	-52.3	157.7	-30.5
cash-flows.row.effect-of-forex-changes-on-cash	1.4	-9.9	4.1	9.7	-3	-18	31.7	-23.2	-32.3	-9.9	5.4	6.2	13.1	20.1	0.3	-9.8	25.7	13.4	2.7	0.9	-0.3	0.5	-8.1
cash-flows.row.net-change-in-cash	-1.8	-27.6	30.1	19.2	-45.5	-130.7	-139.7	-74.1	-80.6	75.9	75	-125.9	-17.2	16.1	13.1	-42.5	232.5	17.5	102.8	65.7	-46.5	140.7	-14.5
cash-flows.row.cash-at-end-of-period	158.7	160.6	188.2	158.2	139	158.2	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1
cash-flows.row.cash-at-beginning-of-period	160.6	188.2	158.2	139	184.5	288.9	428.6	502.7	583.3	507.4	432.4	558.3	575.5	559.3	546.2	588.7	356.2	338.7	235.9	170.3	216.8	76.1	90.6
cash-flows.row.operating-cash-flow	16.2	8.3	42.8	30.1	20.3	74	21.2	128	140.1	165.1	108.3	59.5	170.4	173.9	154.1	269.3	274.2	106.2	111.7	132.8	10.1	48.7	111.3
cash-flows.row.capital-expenditure	-69.1	-44.3	-38.1	-73.9	-76.4	-51.8	-32.3	-19	-14.4	-18.5	-22.6	-61.2	-50.7	-37.2	-17.1	-35.4	-53.8	-11.3	-24.9	-14.2	-11.8	-45.6	-74.4
cash-flows.row.free-cash-flow	-52.9	-36	4.7	-43.8	-56.1	22.2	-11.1	108.9	125.7	146.6	85.7	-1.7	119.6	136.7	137	233.9	220.4	94.9	86.8	118.6	-1.7	3	36.8

Income Statement Row

Natural Beauty Bio-Technology Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of 0157.HK is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	336	335.9	487.8	410.7	438.4	369.5	399.6	475.2	506.9	505.8	439.4	483.4	591.3	485.4	538.1	592.7	450.1	363.7	357.9	358.1	320.1	306.3	254.6
income-statement-row.row.cost-of-revenue	157.3	170.6	206	193.4	190.1	146.7	94.5	122.4	109.4	117	106.3	103.6	122.2	130	122.9	86.1	77.6	68.7	73.3	82.3	61.2	86.8	63.8
income-statement-row.row.gross-profit	178.7	165.3	281.8	217.2	248.3	222.9	305.1	352.9	397.5	388.8	333.1	379.8	469.1	355.4	415.2	506.6	372.6	295	284.6	275.9	258.9	219.5	190.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.operating-expenses	182.5	188.7	237	212.9	209.2	186.7	162.7	162.8	238.8	286	259.4	227.7	295.5	279.5	230.8	198.1	164.3	167.7	207.8	176.5	194.9	162.8	117.2
income-statement-row.row.cost-and-expenses	339.8	359.3	443.1	406.4	399.3	333.4	257.2	285.2	348.2	403	365.7	331.3	417.6	409.5	353.7	284.2	241.8	236.4	281.1	258.7	256.1	249.6	181
income-statement-row.row.interest-income	1.5	1.7	2.1	1.7	1.6	3	4.3	6.2	11.7	13.5	9.3	7	0	0	2.4	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	5.8	7	4.5	3.5	-0.4	-1	-6.1	-2.4	8.5	-26.3	0.2	-4.6	-10.2	7.7	1.4	-42.2	-28.2	108.3	145.9	112.6	125.3	103.6	76.2
income-statement-row.row.total-operating-expenses	-8.1	-0.1	3.7	4.7	-2.1	1.8	9	33.3	19.7	-10.2	19.9	0	0	0	0	0	-0.3	47.1	43.1	-0.3	0	2	2.3
income-statement-row.row.interest-expense	8.1	6.2	4.9	2.7	1.3	0	0	0	0	0	0	-3.3	0	-0.6	-8.1	0.1	0.4	-47.1	-43.1	0.3	-0.7	-3.3	-3.6
income-statement-row.row.depreciation-and-amortization	26.6	34.3	35	37.3	30.9	24.4	20.6	22.4	33.8	38.5	39.2	33.5	23.2	19.5	21.6	17.1	17.5	21.8	25.6	7.8	-19.5	-28.4	-6.4
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-3.8	-23.4	44.7	4.3	39.1	37.3	137.8	162.9	150.7	126.4	63.1	155.3	173.6	75.8	186.8	308.5	208.3	127.3	76.8	99.4	83.5	85.1	79.9
income-statement-row.row.income-before-tax	-11.9	-23.5	48.5	9	37	39.2	146.7	196.2	170.4	116.3	83.1	155.3	173.6	75.8	186.8	308.5	208	174.5	119.8	99.1	83.5	87	82.2
income-statement-row.row.income-tax-expense	3.2	6.9	13.2	1.2	15.1	12.9	41.4	47.8	33.6	44.8	24.6	36.1	58.5	45.1	42.8	69.9	29.2	51.6	38.8	36.3	30.1	21.9	12.5
income-statement-row.row.net-income	-15.1	-30.5	35.3	7.8	21.9	26.3	105.4	148.4	136.8	71.5	58.3	119.3	115.1	31.3	149.6	238.5	178.7	122.8	81	62.7	54.1	66.5	71

Similar Stocks

Frequently Asked Question

What is Natural Beauty Bio-Technology Limited (0157.HK) total assets?

Natural Beauty Bio-Technology Limited (0157.HK) total assets is 882583000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.532.

What is company free cash flow?

The free cash flow is -0.026.

What is enterprise net profit margin?

The net profit margin is -0.045.

What is firm total revenue?

The total revenue is -0.011.

What is Natural Beauty Bio-Technology Limited (0157.HK) net profit (net income)?

The net profit (net income) is -15111000.000.

What is firm total debt?

The total debt is 186287000.000.

What is operating expences number?

The operating expences are 182497000.000.

What is company cash figure?

Enretprise cash is 0.000.